Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

Clinical trial NCT04966741 · COMPLETED

Trial details

NCT number: NCT04966741
Sponsor: Rhythm Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bardet-Biedl Syndrome POMC Deficiency Obesity PCSK1 Deficiency Obesity LEPR Deficiency Obesity

Start date: 2022-03-08
Primary completion: 2023-09-18
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.